2023
DOI: 10.3390/v15071595
|View full text |Cite
|
Sign up to set email alerts
|

Current Perspectives on the Management of Herpesvirus Infections in Solid Organ Transplant Recipients

Abstract: Solid organ transplant recipients (SOTRs) are at high risk of human herpesvirus (HHV)-related morbidity and mortality due to the use of immunosuppressive therapy. We aim to increase awareness and understanding of HHV disease burden in SOTRs by providing an overview of current prevention and management strategies as described in the literature and guidelines. We discuss challenges in both prevention and treatment as well as future perspectives.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 186 publications
(267 reference statements)
0
3
0
Order By: Relevance
“…Herpes simplex 1 (HSV1) and Herpes simplex 2 (HSV2) manifestations resemble those of the general population often with more severe and extended forms [47]. Varicella Zoster Virus (VZV) incidence is higher in thoracic transplant recipients and has been associated with a higher degree of immunosuppression and with acute rejection [48,49]. Cutaneous forms may be multidermatomal or disseminated and should be the exclusion of disseminated forms, such as pneumonia or hepatitis [50].…”
Section: Virusesmentioning
confidence: 99%
See 1 more Smart Citation
“…Herpes simplex 1 (HSV1) and Herpes simplex 2 (HSV2) manifestations resemble those of the general population often with more severe and extended forms [47]. Varicella Zoster Virus (VZV) incidence is higher in thoracic transplant recipients and has been associated with a higher degree of immunosuppression and with acute rejection [48,49]. Cutaneous forms may be multidermatomal or disseminated and should be the exclusion of disseminated forms, such as pneumonia or hepatitis [50].…”
Section: Virusesmentioning
confidence: 99%
“…No specific treatment is available. Reduction of immunosuppression and switch to mTOR inhibitors are commonly used strategies [49]. Topical, intralesional or systemic chemotherapy may be considered in severe cases [56].…”
Section: Virusesmentioning
confidence: 99%
“…These viruses have a latent form in their infectious cycle [36,37] that is resistant to known therapeutic agents. Moreover, latent human or animal viruses can contribute significantly to graft rejection in transplantation [38] or xenotransplantation [39]. Therefore, alternative, effective, and safe strategies to combat human viruses are urgently needed.…”
mentioning
confidence: 99%